Hints and tips:
Related Special Reports
..., who was formerly with multinational healthcare group, DaVita....
...A spokesperson for the Department of Health and Social Care did not comment on whether it had received a satisfactory explanation....
...Typically, the home setting cost of providing care is lower.” Four-fifths of patients would select at-home treatment if it were available, according to the American Journal of Kidney Diseases....
...(Vifor Fresenius Medical Care has the deal for marketing rights outside the US.)...
...He said the infected worker had provided care on “multiple occasions” to Thomas Eric Duncan, who became the first case of Ebola diagnosed on US soil after contracting the virus in Liberia....
...As the world’s largest provider of products and services to people requiring kidney dialysis, and with two-thirds of its $14bn of 2012 revenue in the US, Fresenius Medical is in the line of fire; DaVita...
...Baxter has long specialised in home-based dialysis, and the acquisition would expand its influence in hospital-based care....
...“DaVita currently executes on its integrated care mission with thousands of physician partners across the country for specialised kidney care services,” said Kent Thiry, DaVita’s chief executive, on Monday...
...The companies likely to be competing for the final stage of the contract are all large non-UK corporations: Davita of the US, Fresenius Medical Care of Germany and Diaverum of Sweden....
...Fresenius Medical Care, which provides kidney dialysis services to 10 per cent of patients worldwide, rose 2.3 per cent to €33.97 as fears about the impact of new US Medicare restrictions receded....
...That option is worth much, but it is very hard to price when it is unclear which licensees are likely to take advantage of the opportunity and which could care less....
...US-based Genzyme agreed to buy Bone Care International in a $600m deal that will expand its line of treatments for kidney disease, reports Reuters in New York....
...Shares in Gambro were suspended from trading following a report that the Swedish medical care company could be on the verge of selling its main kidney dialysis operation in a $3bn deal....
International Edition